Nathan J. Dowden, Chief Operating Officer at Entrada Therapeutics, Inc. (TRDA), sold 1,777 shares at $15.15 ($27K) on 2022-09-08, disclosed to the SEC on 2022-09-12.
Scheduled sale ($27k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.15 | 912 | $14K | 51.5% |
| 2 | $15.06 | 865 | $13K | 48.5% |
| Total | $15.11 avg | 1,777 | $27K | 100% |
| Filing → |
| TRDA | SELL | 2024-09-30 | $14K | — | Filing → |
| TRDA | SELL | 2024-09-10 | $35K | — | Filing → |
| TRDA | SELL | 2024-08-20 | $873K | — | Filing → |